Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Low-Dose Leptin and T3 on Metabolic Phenotypes in Formerly-Obese
NCT00073242Phase 3Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Jul 2000
- Primary completion
- Jul 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of leptin, liothyronine in obesity, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Jul 2000; status: completed.
02
Drugs
leptinliothyronine
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00073242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00073242.